ALQA - Alliqua BioMedical, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue18,24012,1774,786.131
Cost of Revenue6,6555,2273,270.955
Gross Profit11,5856,9501,515.176
Operating Expenses
Research Development859715715
Selling General and Administrative28,06032,86626,386.606
Non Recurring13,8542,876546.97
Total Operating Expenses---
Operating Income or Loss-31,188-29,507-25,418.4
Income from Continuing Operations
Total Other Income/Expenses Net6102,137-12.651
Earnings Before Interest and Taxes-30,578-27,370-25,431.051
Interest Expense2,5411,5650.384
Income Before Tax-33,119-28,935-25,431.435
Income Tax Expense-715-1,71814
Minority Interest---
Net Income From Continuing Ops-32,404-27,217-25,445.435
Non-recurring Events
Discontinued Operations4,1611,2001,200
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-28,243-26,017-25,445.435
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-28,243-26,017-25,445.435